Perrigo | PRGO - Заемный капитал





Заемный капитал Изменить Дата
AbbVie USD 58.94B 4.03B 2025-12
Abbott USD 29.64B 19.74B 2026-03
Bayer EUR 30.68B 1.15B 2026-03
Bristol-Myers Squibb USD 42.15B 698M 2026-03
Coherus Biosciences USD 51.08M 496K 2025-12
Dr.Reddys Laboratories INR 12.2B 595M 2026-03
Eli Lilly USD 39.37B 1.5B 2026-03
J&J USD 37.53B 1.91B 2026-03
Merck USD 46.67B 77M 2026-03
Nestle CHF 46.25B 742M 2025-12
Pacira USD 367.66M 4.53M 2026-03
Perrigo USD 3.62B 17.5M 2026-03
Pfizer USD 60.57B 1.08B 2026-03
Phibro Animal Health USD 597.68M 5.92M 2026-03
Prestige Brands USD 1.01B 40.28M 2026-03
Reckitt Benckiser GBP 7.24B 590M 2024-12
Sanofi EUR 13.84B 1.88B 2026-03
Supernus Pharmaceuticals USD 400.38M 21.13M 2022-03
Teva Pharmaceutical Industries USD 14.02B 971M 2026-03
Xeris Pharmaceuticals USD 221.22M 889K 2026-03
Zoetis USD 9.04B 3M 2026-03